NCS Multistage sells engineered products and services that help oil and gas producers complete and optimize horizontal wells. The company's primary offering is fracturing systems — specifically, casing-installed sliding sleeves and downhole frac isolation assemblies — that enable "pinpoint stimulation," a technique where each entry point into a formation is stimulated individually. NCS also holds a 50% controlling interest in Repeat Precision, which makes frac plugs and perforating guns for the more common plug-and-perf completion method, giving NCS a foothold in both major completion approaches. Beyond completions, NCS sells well construction products (casing buoyancy systems, liner hangers, toe initiation sleeves), tracer diagnostics services that evaluate completion effectiveness and production profiles, and enhanced recovery systems for maturing wells. NCS sells primarily direct to E&P companies in Canada and the U.S., through local partners internationally, and Repeat Precision also sells through oilfield distributors. Canada accounts for the majority of revenue, with heavy exposure to the Montney formation and meaningful seasonal swings. The business model is consumable-driven — sliding sleeves and frac plugs are single-use per well completion, so revenue scales directly with drilling and completion activity. Key revenue drivers include Canadian rig count, the number of frac stages per well as laterals lengthen, and international mix, as the North Sea and Middle East carry above-average margins. NCS outsources most manufacturing, making it asset-light with low capex needs and strong free cash flow conversion. The company also earns modest IP licensing income from its patent portfolio.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →